Education
About Us
Working with TipRanks
Follow Us
Theratechnologies Inc (THTX)
NASDAQ:THTX
Th1902
Epithelial Ovarian Cancer, Solid Tumor, Endometrial Cancer, Small-cell Lung Cancer, Prostate Cancer, Thyroid Cancer, Cutaneous Melanoma, Hormone Receptor-Positive Breast Cancer, Tnbc - Triple-Negative Breast Cancer, Sort1+ Cancers
Phase I
Active Not Recruiting
TH1902 in Patients With Advanced Solid Tumors
Jan 07, 2021
―
Tesamorelin
Hiv, Diabetic Retinopathy
Phase IV
Terminated
Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA®
May 02, 2012
―
Tesamorelin
Chronic Obstructive Pulmonary Disease (COPD)
Phase II
Terminated
Efficacy and Safety Study of Tesamorelin in Chronic Obstructive Pulmonary Disease (COPD) Subjects With Muscle Wasting
Jul 05, 2011
―
Tesamorelin
Hiv Infections, Lipodystrophy
Phase III
Completed
TH9507 Extension Study in Patients With HIV-Associated Lipodystrophy
Jan 23, 2008
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Theratechnologies Inc (THTX) have in its pipeline
THTX is currently developing the following drugs: Th1902, Tesamorelin, Tesamorelin. These drug candidates are in various stages of clinical development as the company works toward FDA approval.